glp 1 for mcas Do glucagon‑like peptide‑1 (GLP‑1) receptor agonists such as semaglutide, liraglutide, dulaglutide, and tirzepatide improve symptoms of postural orthostatic tachycardia syndrome (POTS) and mast‑cell activation syndrome ( MCAS)? GLP-1 and Anesthesia: Considerations and
Description
Ultimately, the increased risks of death and disease associated with excessive ultra-processed food consumption appear to be driven largely by intake of sweetened beverages and animal-based foods, such as burgers, chicken nuggets, and fish sticks

What the GLP-1 class is, why it is prescription-only, how telehealth assessment works, and why eligibility is decided by a practitioner

Hengrui Pharma & Kailera Therapeutics Present Additional Data from Phase 3 Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531 at Obesity Week...

Virta plans to reach profitability by the end of the year, buoyed by its expanded weight loss business